HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaohong Wang Selected Research

Hypoxia (Hypoxemia)

7/2022Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration delivery for enhanced photo-gene therapy towards glioma.
1/2019Histone deacetylase-1 as a prognostic factor and mediator of gastric cancer progression by enhancing glycolysis.
1/2018Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
12/2016Integrin-Linked Kinase Senses Hypoxia During Scar Angiogenesis.
2/2015Role of HLA-G1 in trophoblast cell proliferation, adhesion and invasion.
1/2014MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF.
1/2012The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury.
9/2009Stem cells for myocardial repair with use of a transarterial catheter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaohong Wang Research Topics

Disease

105Neoplasms (Cancer)
05/2024 - 01/2004
74Polyps
03/2024 - 06/2011
47Inflammation (Inflammations)
03/2024 - 04/2007
40Infections
01/2024 - 11/2002
29Neoplasm Metastasis (Metastasis)
05/2024 - 12/2011
21Stomach Neoplasms (Stomach Cancer)
10/2022 - 02/2013
18Breast Neoplasms (Breast Cancer)
03/2024 - 01/2015
16Carcinogenesis
02/2024 - 04/2009
15Wounds and Injuries (Trauma)
03/2024 - 09/2015
15Cysts
01/2023 - 05/2004
12Fibrosis (Cirrhosis)
04/2024 - 01/2012
11Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2022 - 05/2004
10Osteoporosis
04/2022 - 01/2011
9Myocardial Infarction
01/2023 - 01/2006
9Osteosarcoma (Osteogenic Sarcoma)
10/2021 - 11/2009
9Lung Neoplasms (Lung Cancer)
01/2020 - 05/2015
9Ischemia
01/2020 - 06/2008
9Infarction (Infarctions)
01/2014 - 08/2004
8COVID-19
12/2023 - 12/2020
8Nematode Infections
12/2022 - 07/2007
8Reperfusion Injury
12/2022 - 11/2008
8Hypoxia (Hypoxemia)
07/2022 - 09/2009
8Necrosis
01/2020 - 05/2011
7Chronic Obstructive Pulmonary Disease (COPD)
09/2023 - 03/2015
7Pancreatitis
02/2023 - 02/2015
7Malaria
01/2023 - 01/2017
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2021 - 05/2015
7Sepsis (Septicemia)
01/2020 - 09/2009
6Spontaneous Abortion (Miscarriage)
04/2024 - 10/2012
6Cognitive Dysfunction
12/2023 - 01/2010
6Virus Diseases (Viral Diseases)
08/2023 - 01/2013
6Pneumonia (Pneumonitis)
06/2023 - 07/2017
6Carcinoma (Carcinomatosis)
01/2023 - 01/2015
6Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 12/2011
6Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 12/2012
6Human Influenza (Influenza)
08/2021 - 08/2009
6Hypertrophy
06/2021 - 04/2006
6Hepatocellular Carcinoma (Hepatoma)
01/2018 - 11/2002
6Bone Diseases (Bone Disease)
01/2017 - 01/2011
5Liver Diseases (Liver Disease)
02/2024 - 07/2014
5Cerebral Hemorrhage
01/2024 - 12/2018
5Disease Progression
12/2023 - 10/2016
5Chronic Hepatitis B
06/2023 - 03/2014

Drug/Important Bio-Agent (IBA)

84Proteins (Proteins, Gene)FDA Link
12/2023 - 03/2005
73PolyphosphatesIBA
03/2024 - 08/2012
54PolymersIBA
03/2024 - 06/2011
29Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2010
26Phosphates (Orthophosphate)IBA
03/2024 - 05/2006
24Alkaline PhosphataseIBA
12/2022 - 06/2011
23Adenosine Triphosphate (ATP)IBA
03/2024 - 08/2006
22CalciumIBA
03/2024 - 01/2011
21MicroRNAs (MicroRNA)IBA
03/2023 - 07/2008
21EnzymesIBA
12/2022 - 08/2006
19Messenger RNA (mRNA)IBA
11/2023 - 01/2004
17Peptides (Polypeptides)IBA
12/2022 - 03/2003
16CytokinesIBA
01/2022 - 01/2013
14SaltsIBA
01/2022 - 06/2011
13LigandsIBA
12/2022 - 02/2011
13CollagenIBA
04/2022 - 02/2014
12HydrogelsIBA
04/2024 - 01/2014
12CateninsIBA
02/2024 - 11/2010
12Therapeutic UsesIBA
01/2023 - 01/2012
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2024 - 01/2013
11Phosphotransferases (Kinase)IBA
01/2023 - 10/2011
11DNA (Deoxyribonucleic Acid)IBA
01/2023 - 01/2003
11IonsIBA
12/2022 - 05/2014
11Glucose (Dextrose)FDA LinkGeneric
09/2022 - 08/2013
11Small Interfering RNA (siRNA)IBA
07/2022 - 01/2013
11Antiviral Agents (Antivirals)IBA
01/2022 - 01/2011
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 04/2006
10Biocompatible Materials (Biomaterials)IBA
03/2022 - 06/2009
10Durapatite (Hydroxylapatite)IBA
12/2020 - 01/2011
9Interleukin-6 (Interleukin 6)IBA
01/2024 - 11/2011
9Transcription Factors (Transcription Factor)IBA
06/2021 - 04/2009
9VaccinesIBA
01/2019 - 08/2009
8Silicon Dioxide (Silica)FDA LinkGeneric
01/2024 - 07/2011
8Oxygen (Dioxygen)IBA
12/2023 - 01/2016
8Anti-Bacterial Agents (Antibiotics)IBA
09/2023 - 01/2011
8LipidsIBA
01/2023 - 01/2017
8SolutionsIBA
12/2022 - 01/2015
8InterferonsIBA
11/2020 - 01/2005
8MineralsIBA
01/2019 - 01/2011
8AntigensIBA
01/2019 - 01/2004
7RNA (Ribonucleic Acid)IBA
10/2022 - 01/2003
7AlginatesIBA
12/2021 - 05/2010
6Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024 - 10/2014
6Retinaldehyde (Retinal)IBA
11/2023 - 06/2015
6Indicators and Reagents (Reagents)IBA
10/2023 - 01/2010
6GlucocorticoidsIBA
10/2023 - 02/2005
66-methyladenineIBA
02/2023 - 12/2019
6Long Noncoding RNAIBA
10/2022 - 01/2017
6methylallyl trisulfide (MATS)IBA
01/2022 - 09/2015
5AcidsIBA
03/2024 - 01/2015

Therapy/Procedure

61Therapeutics
03/2024 - 08/2004
16Drug Therapy (Chemotherapy)
03/2024 - 05/2011
9Radiotherapy
11/2023 - 01/2015
8Immunotherapy
05/2024 - 09/2014
7Ligation
01/2023 - 08/2007
7Transplantation
01/2012 - 04/2006
5Precision Medicine
09/2023 - 01/2022